Publications with RKI participation

• Publications on COVID-19 in the Epidemiological Bulletin (vaccination and other topics, in German)
• Publications on COVID-19 in the Journal of Health Monitoring
• Publications on COVID-19 in the Bundesgesundheitsblatt (abstracts are available in english)
• Publications with RKI participation, including preprints

Publications on COVID-19 in the Epidemiological Bulletin (vaccination and other topics, in German)

COVID-19 vaccination

• COVID-19-Impfempfehlung und wissenschaftliche Begründungen der STIKO
• Regionale Inanspruchnahme der COVID-19-Impfung - Eine Sonderauswertung mit Daten bis Dezember 2021, Epid Bull 27/2022 online vorab (7.7.2022)
• Die Impfung gegen COVID-19 in Deutschland zeigt eine hohe Wirksamkeit gegen SARS-CoV-2-Infektionen, Krankheitslast und Sterbefälle (Analyse der Impfeffekte im Zeitraum Januar bis Juli 2021), Epid Bull 35/2021 online vorab (6.8.2021)
• Welche Impf­quote ist not­wendig, um COVID-19 zu kon­trollie­ren?, Epid Bull 27/2021 (online vorab am 5.7.2021)
• Wie gut schützt die COVID-19-Impfung vor SARS-CoV-2-Infektionen und -Transmission?, Epid Bull 19/2021 (online vorab am 6.5.2021)
• Effekte der COVID-19-Impfung auf Inzidenz und Todesfälle in der älteren Bevölkerung in Deutschland: erste Ergebnisse einer ökologischen Analyse, Epid Bull 19/2021 (12.5.2021)
• Hierarchisierung von Risiko­faktoren für schwere COVID-19-Er­kran­kungs­verläufe im Kontext der COVID-19-Schutz­impfungen: Eine gepoolte GKV-Routine­daten­analyse basierend auf 30 Mio. Ver­si­cher­ten, Epid Bull 19/2021 (online vorab am 28.4.2021)
• Einfluss von Impfungen und Kontakt­reduktionen auf die dritte Welle und pers­pektivische Rück­kehr zu prä-pande­mischem Kontakt­verhalten, Epid Bull 13/2021 (online vorab am 31.3.2021)

Other topics

• Erkenntnisse aus SARS-CoV-2-Ausbrüchen während der ersten Pandemiephase in Settings mit prekären Wohnverhältnissen in Göttingen, Epid Bull 34/2023 (24.8.2023)
• Erfahrungen der lokalen Gesund­heits­behörden in Deutsch­land mit dem Krisen­management während der COVID-19-Pandemie in den Jahren 2020 – 2022, Epid Bull 32/2023 (10.8.2023)
• Retrospektive Evaluation eines Prognose­modells für die Betten­belegung durch COVID-19-Patienten und -Patientinnen auf deutschen Intensiv­stationen, Epid Bull 24/2023 (15.6.2023)
• COVID-19-Raten unter Kindern und Erwachsenen — Ergebnisse aus dem bevölkerungsbasierten Online-Portal GrippeWeb, Epid Bull 13/2023 (30.3.2023)
• Long COVID – eine Heraus­forderung für Public Health und Gesund­heits­forschung, Epid Bull 44/2022 (3.11.2022)
• Untersuchung und Eindämmung eines SARS-CoV-2-Alpha-Ausbruchs in einer Pflegeeinrichtung im Landkreis Dithmarschen, Juni 2021, Epid Bull 43/2022 (27.10.2022)
• Dritte Aktualisierung der „Retrospektiven Phaseneinteilung der COVID-19-Pandemie in Deutschland“, Epid Bull 38/2022 (22.9.2022)
• Wie gut und wie lange schützt eine SARS-CoV-2-Infektion vor einer Reinfektion?, Epid Bull 31/2022 (4.8.2022)
• COVID-19-Pandemie: Surveillance und Studien des Robert Koch-Instituts zur Lage- und Maßnahmenbewertung, Epid Bull 29/2022 (21.7.2022)
• In(tra)-Action Review (IAR): COVID-19-Management an IGV-benannten Flughäfen in Deutschland, Epid Bull 23/2022 (9.6.2022)
• COVID-19-Infektions­geschehen und Maß­nahmen in Schulen – Aus­wer­tungen der Daten auf der Webseite der Kultus­minister­konferenz, Epid Bull 17/2022 (28.4.2022)
• „Systematische Überwachung von SARS-CoV-2 im Abwasser“ – Start eines nationalen Pilotprojekts, Epid Bull 13/2022 (31.3.2022)
• Zweite Aktualisierung der „Retrospektiven Phaseneinteilung der COVID-19-Pandemie in Deutschland“, Epid Bull 10/2022 (10.3.2022)
• Prävention des Eintrags von SARS-CoV-2 in Kitas: Erfahrungen aus dem Berliner Bezirk Treptow-Köpenick, Januar bis März 2021, Epid Bull 6/2022 (10.2.2022)
• Soziale Ungleichheit und COVID-19 in Deutschland - Wo stehen wir in der vierten Pandemiewelle? Epid Bull 5/2022 (3.2.2022)
• Meldedaten und KiTa-Register ergänzen sich in der Bewertung der Dynamik der SARS-CoV-2-Ausbrüche in Kindertageseinrichtungen, Epid Bull 3/2022 (20.1.2022)
• COSIK – COVID-19-Surveillance in Krankenhäusern, Epid Bull 2/2022 (13.1.2022)
• Update: Erfassung der SARS-CoV-2-PCR-Test­zahlen in Deutschland und die Ent­wick­lung der Test­zahlen in ärzt­lichen Praxen, Epid Bull 47/2021 (25.11.2021)
• Warum müssen wir Kinder vor einer SARS-CoV-2-Infektion schützen? Epid Bull 46/2021 online vorab (2.11.2021)
• Aktualisierung zur „Retrospektiven Phaseneinteilung der COVID-19-Pandemie in Deutschland“, Epid Bull 37/2021 (online vorab am 25.8.2021)
• Ein­satz von Antigen­tests in Ein­richtun­gen in Deutsch­land – Ergeb­nisse einer RKI-Um­frage, Epid Bull 36/2021, online vorab (23.8.2021)
• Reise­asso­ziierte COVID-19-Fälle im Stadt­kreis Offen­bach und Deutsch­land, Juni-No­vem­ber 2020: Er­kran­kungs­be­ginne und SARS-CoV-2-Testun­gen nach Ein­reise, Epid Bull 32/2021 (12.8.2021)
• ICD-10-Code-basierte syn­dro­mische Surveillance akuter Atem­wegs­erkran­kun­gen mit COVID-19 im ambu­lanten Bereich, Epid Bull 30/2021 (29.7.2021)
• PCR-Test­kapa­zi­täten nutzen für Personen­gruppen ohne Impf­möglich­keit: serielles Screening von Kindern in KiTas und Grund­schulen mittels Lolli-Pool-PCR-Tes­tun­gen auf SARS-CoV-2 als Teil eines Multi­kompo­nenten-Prä­ven­tions­konzepts, Epid Bull 26/2021 (1.7.2021)
• Erfassung der SARS-CoV-2-PCR-Testzahlen in Deutschland, Epid Bull 24/2021 (online vorab am 10.6.2021)
• Kommuni­ka­tions­emp­feh­lungen zur Ver­besse­rung des Ver­hal­tens bei der Ver­wen­dung von PoC Antigen-Schnell­tests und Selbst­tests, Epid Bull 20/2021 (online vorab am 17.5.2021)
• Hierarchisierung von Risiko­faktoren für schwere COVID-19-Er­kran­kungs­verläufe im Kontext der COVID-19-Schutz­impfungen: Eine gepoolte GKV-Routine­daten­analyse basierend auf 30 Mio. Ver­si­cher­ten, Epid Bull 19/2021 (online vorab am 28.4.2021)
• Spektrum diagnostischer Proben zum Nachweis von SARS-CoV-2, Selbstabnahme durch Patientinnen und Patienten und möglicher Einsatz von Antigen-Tests, Epid Bull 17/2021 (online vorab am 19.4.2021)
• Antigen­tests als ergänzendes Instrument in der Pandemie­bekämpfung, Epid Bull 17/2021 (online vorab am 1.4.2021)
• Retrospektive Phaseneinteilung der COVID-19-Pandemie in Deutschland bis Februar 2021, Epid Bull 15/2021 (online vorab am 22.3.2021)
• Einfluss von Impfungen und Kontakt­reduktionen auf die dritte Welle und pers­pektivische Rück­kehr zu prä-pande­mischem Kontakt­verhalten, Epid Bull 13/2021 (online vorab am 31.3.2021)
• Epidemiologie von COVID-19 im Schulsetting, Epid Bull 13/2021 (online vorab am 25.2.2021)
• Betrachtung der reiseassoziierten COVID-19-Fälle im Sommer 2020 unter Berücksichtigung der Schulferien, Reisetätigkeit und Testkapazitäten, Epid Bull 8/2021 (8.2.2021)
• Was ist bei Antigentests zur Eigenanwendung (Selbsttests) zum Nachweis von SARS-CoV-2 zu beachten? Epid Bull 8/2021 (22.2.2021)
• Einfluss der COVID-19-Pandemie auf die Anzahl der gemäß IfSG meldepflichtigen Nachweise von Erregern mit Antibiotikaresistenzen und C. difficile-Infektionen, Epid Bull 7/2021 (18.02.2021)
• Die Auswirkun­gen der COVID-19-Pan­demie und asso­ziierter Public-Health-Maß­nah­men auf andere melde­pflichtige Infektions­krankheiten in Deutsch­land (MW 1/2016 – 32/2020), Epid Bull 7/2021 (online vorab, 12.2.2021)
• Wissenschaftliche Begleitung und Evaluation der HIV-Präexpositionsprophylaxe (PrEP) als Leistung der gesetzlichen Krankenversicherung – das Projekt EvE-PrEP in Zeiten der SARS-CoV-2-Pandemie, Epid Bull 6/2021 (11.02.2021)
• Erfassung der SARS-CoV-2-Testzahlen in Deutschland (Stand 09.02.2021), Epid Bull 6/2021
• Ergebnisse sero­epide­mio­lo­gischer Studien zu SARS-CoV-2 in Stich­proben der All­ge­mein­be­völ­ke­rung und bei Blut­spen­de­rinnen und Blut­spendern in Deutsch­land (Stand 3.12.2020), Epid Bull 50/2020 (10.12.2020)
• Erfassung der SARS-CoV-2-PCR-Testzahlen in Deutschland, EpidBull 49/2020 (3.12.2020)
• Aktualisierung der Nationalen Test­strategie und Neuverkündung der Coronavirus-Test­verordnung, EpidBull 43/2020 (22.10.2020)
• Neuerungen in der Regelung der Quarantäne für Haushalte, EpidBull 43/2020 (22.10.2020)
• Höhere Letalität und lange Beatmungs­dauer unter­scheiden COVID-19 von schwer verlau­fenden Atem­wegs­infektionen in Grippe­wellen, Epid Bull 41/2020 online vorab (28.8.2020)
• Abwägung der Dauer von Quarantäne und Isolierung bei COVID-19, Epid Bull 39/2020 online vorab (23.9.2020)
• Infektionsumfeld von erfassten COVID-19-Ausbrüchen in Deutschland, Epid Bull 38/2020 online vorab (21.8.2020)
• Sero­logische Unter­suchun­gen von Blut­spenden auf Anti­körper gegen SARS-CoV-2 – SeBluCo-Stu­die, Epid Bull 29/20 (16.7.2020)
• Hinweise für COVID-19-Prozesse im Flugverkehr, Epid Bull 29/2020 (16.7.2020)
• Inanspruch­nahme deutscher Not­auf­nah­men während der COVID-19-Pan­de­mie – der Not­auf­nahme-Situa­tions­report (SitRep), Epid Bull 27/2020 (2.7.2020)
• Nutzung von Routine­daten aus Not­auf­nahmen: Be­schrei­bung zweier Häufungen von Not­aufnahme­vor­stellungen in Wolfsburg und Stuttgart während der COVID-19-Pandemie, Epid Bull 27/28 2020 (2.7.2020)
• Erfassung der SARS-CoV-2-Testzahlen in Deutschland (Update vom 11.6.2020) (Epidemiologisches Bulletin 24/2020; Erscheinungsdatum: 11.6.2020)
• Wiederaufnahme von Reisen und Tourismus Legionellenwachstum vorbeugen – Erkrankungen verhindern (Epidemiologisches Bulletin 24/2020; Erscheinungsdatum: 11.6.2020)
• Erfassung der SARS-CoV-2-Testzahlen in Deutschland (Update vom 4.6.2020) (Epidemiologisches Bulletin 23/2020; Erscheinungsdatum: 4.6.2020)
• Erfassung der SARS-CoV-2-Testzahlen in Deutschland (Update vom 28.5.2020) (Epidemiologisches Bulletin 22/2020; Erscheinungsdatum: 28.5.2020)
• Fachliche Einschätzung zur Durchführung von Temperaturmessungen und anderen Methoden im Rahmen von Entry- und Exit-Screening an Flughäfen während der COVID-19-Lage, Deutschland (Epidemiologisches Bulletin 20/2020; Erscheinungsdatum: 14.5.2020)
• Der erste Monat mit COVID-19-Fällen im Landkreis
  Wittenberg, Sachsen-Anhalt (Epidemiologisches Bulletin 20/2020; Erscheinungsdatum: 21.4.2020)
• Erfassung der SARS-CoV-2-Testzahlen in Deutschland (Update vom 14.5.2020) (Epidemiologisches Bulletin 20/2020; Erscheinungsdatum: 14.5.2020)
• Händedesinfektion unter den Bedingungen der SARS-CoV-2-Pandemie (Epidemiologisches Bulletin 19/2020; Erscheinungsdatum 4.5.2020)
• Wiedereröffnung von Bildungseinrichtungen – Überlegungen, Entscheidungsgrundlagen und Voraussetzungen (Epidemiologisches Bulletin 19/2020; Erscheinungsdatum: 23.4.2020)
• Mund-Nasen-Bedeckung im öffentlichen Raum als weitere Komponente zur Reduktion der Übertragungen von COVID-19 (Epidemiologisches Bulletin 19/2020; Erscheinungsdatum: 14.4.2020)
• Schätzung der aktuellen Entwicklung der SARS-CoV-2-Epidemie in Deutschland - Nowcasting (Epidemiologisches Bulletin 17/2020; Erscheinungsdatum: 23.4.2020)
• Vorläufige Bewertung der Krankheitsschwere von COVID-19 in Deutschland basierend auf übermittelten Fällen gemäß IfSG (Epidemiologisches Bulletin 17/2020; Erscheinungsdatum: 23.4.2020)
• Erfassung der SARS-CoV-2-Testzahlen in Deutschland. (Update vom 15.4.2020) (Epidemiologisches Bulletin 16/2020; Erscheinungsdatum: 16.4.2020)
• Abrupter Rückgang der Raten an Atemwegserkrankungen in der deutschen Bevölkerung (Epidemiologisches Bulletin 16/2020; Erscheinungsdatum: 16.4.2020)
• Erste Ergebnisse zum Verlauf der Grippewelle in der Saison 2019/20: Mit 11 Wochen vergleichsweise kürzere Dauer und eine moderate Anzahl an Influenza-bedingten Arztbesuchen (Epidemiologisches Bulletin 16/2020; Erscheinungsdatum: 16.4.2020)
• Laborbasierte Surveillance SARS-CoV-2 (Epidemiologisches Bulletin 15/2020; Erscheinungsdatum: 9.4.2020)
• Erfassung der SARS-CoV-2-Testzahlen in Deutschland (Epidemiologisches Bulletin 15/2020; Erscheinungsdatum: 9.4.2020)
• Schwereeinschätzung von COVID-19 mit Vergleichsdaten zu Pneumonien aus dem Krankenhaussentinel für schwere akute Atemwegserkrankungen am RKI (ICOSARI) (Epidemiologisches Bulletin 14/2020; Erscheinungsdatum: 27.3.2020)
• COVID-19: Jetzt handeln, vorausschauend planen (Epidemiologisches Bulletin 12/2020; Erscheinungsdatum: 19.3.2020)
• Fachliche Stellungnahme zu Schulschließungen als bevölkerungsbezogene antiepidemische Maßnahme (Epidemiologisches Bulletin 12/2020; Erscheinungsdatum: 19.3.2020)
• Beschreibung des Ausbruchsgeschehens mit dem neuartigen Coronavirus SARS-CoV-2 in Deutschland (Epidemiologisches Bulletin 11/2020; Erscheinungsdatum: 13.3.2020)
• Das RKI stellt umfangreiche Informationen zu Erkrankungen mit dem neuartigen Coronavirus SARS-CoV-2 unter www.rki.de/covid-19 zur Verfügung (Epidemiologisches Bulletin 09/2020, Erscheinungsdatum: 13.2.2020)
• Die Arbeitsgemeinschaft Influenza des RKI erweitert die virologische Surveillance um SARS-CoV-2 (Epidemiologisches Bulletin 09/2020, Erscheinungsdatum: 13.2.2020)
• SARS-CoV-2: Informationen des Robert Koch-Instituts zu empfohlenen Infektionsschutzmaßnahmen und Zielen (Epidemiologisches Bulletin 07/2020; Erscheinungsdatum: 13.2.2020)
• Beschreibung des bisherigen Ausbruchsgeschehens mit dem neuartigen Coronavirus SARS-CoV-2 in Deutschland (Stand: 12. Februar 2020) (Epidemiologisches Bulletin 07/2020; Erscheinungsdatum: 13.2.2020)
• Update zum neuartigen Coronavirus 2019-nCoV (Stand: 30.1.2020) (Epidemiologisches Bulletin 05/2020; Erscheinungsdatum: 30.1.2020)
• Erkrankungen durch ein neuartiges Coronavirus (2019-nCoV) in Wuhan, China (Epidemiologisches Bulletin 03/2020; Erscheinungsdatum: 16.1.2020)
• Informationen des RKI zur Häufung von Pneumonien unklarer Ursache in Wuhan, China (Epidemiologisches Bulletin 02/2020; Erscheinungsdatum: 9.1.2020)

Publications on COVID-19 in the Journal of Health Monitoring

Article series COVID-19

Publications on COVID-19 in the Bundesgesundheitsblatt (abstracts are available in english)

• Menschen mit Migrationsgeschichte in der COVID-19-Pandemie (Bundesgesundheitsblatt 8/2023, 20.7.2023)
• Berufsbedingte Unterschiede bei COVID-19-Morbidität und -Mortalität in Deutschland. Eine Analyse von Krankenkassendaten von 3,17 Mio. Versicherten. (Bundesgesundheitsblatt 8/2023, 19.7.2023)
• Epidemiologie seelischen Wohlbefindens von Kindern und Jugendlichen in Deutschland. Ergebnisse aus 3 Studien vor und während der COVID-19-Pandemie (Bundesgesundheitsblatt 7/2023, 30.5.2023)
• Ausgabe 03/2023: COVID-19 und Public Health: Menschen mit besonderen Risiken und Versorgungsbedarfen. Heft 1: Alter, Krankheit, Behinderung, Schwangerschaft und Geburt
• Etablierung der Genomischen Erreger-Surveillance zur Stärkung des Pandemie- und Infektionsschutzes in Deutschland (Bundesgesundheitsblatt 4/2023, 22.2.2023)
• Ausgabe 12/2022 – COVID-19 und Public Health: Impfungen
• Desinfektionsmittel in der COVID-19-Pandemie: eine Herausforderung (Bundesgesundheitsblatt 1/2022, 8.12.2021)
• Ausgabe 12/2021 – COVID-19 und Public Health: Gesundheit von Kindern und Jugendlichen
• Die Rolle der Epidemiologie in der SARS-CoV-2-Pandemie: Bedeutung, Aufgaben, Methoden und Erkenntnisse (Bundesgesundheitsblatt 9/2021, 3.9.2021)
• Die verschiedenen Phasen der COVID-19-Pandemie in Deutschland: Eine deskriptive Analyse von Januar 2020 bis Februar 2021 (Bundesgesundheitsblatt 9/2021, 10.8.2021)
• SARS-CoV-2-Übertragungswege und Implikationen für den Selbst- und Fremdschutz (Bundesgesundheitsblatt 9/2021, 29.7.2021)
• COVID-19-Patientinnen und -Patienten in Deutschland: Expositionsrisiken und assoziierte Faktoren für Hospitalisierungen und schwere Krankheitsverläufe (Bundesgesundheitsblatt 9/2021, 29.7.2021)
• Soziale Ungleichheit in der regionalen Ausbreitung von SARS-CoV-2 (Bundesgesundheitsblatt 9/2021, 23.7.2021)
• COVID-19-Forschungsdaten leichter zugänglich machen – Aufbau einer bundesweiten Informationsinfrastruktur (Bundesgesundheitsblatt 9/2021, 23.7.2021)
• Epidemiologische Ansätze zur Klärung wichtiger Forschungsfragen zu COVID-19 – eine Übersicht (Bundesgesundheitsblatt 9/2021, 13.7.2021)
• Ausgabe 04/2021 – COVID-19 und Public Health: Reaktionen des öffentlichen Gesundheitsdienstes
• Risikokommunikation bei der Eindämmung der COVID-19-Pandemie: Herausforderungen und Erfolg versprechende Ansätze (Bundesgesundheitsblatt 3/2021, 9.2.2021)
• Vertrauen der Bevölkerung in staatliche Institutionen im ersten Halbjahr der Coronapandemie: Erkenntnisse aus dem Projekt COVID-19 Snapshot Monitoring (COSMO) (Bundesgesundheitsblatt 3/2021, 29.1.2021)

Publications with RKI participation, including preprints

• Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 (Euro Surveill., 2024, Jan 18)
• Case-Control Study of Behavioural and Societal Risk Factors for Sporadic SARS-CoV-2 Infections, Germany, 2020-2021 (CoViRiS Study). (Epidemiol Infect., 2024, Jan 15)
• Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease. (Virol J., 2024, Jan 10)
• Recombination-aware phylogenetic analysis sheds light on the evolutionary origin of SARS-CoV-2. (Sci Rep. 2024, Jan 4)
• Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study. (BMJ Open., 2024, Jan 4)
• How the COVID-19 pandemic and related school closures reduce physical activity among children and adolescents in the WHO European Region: a systematic review and meta-analysis (International Journal of Behavioral Nutrition and Physical Activity, 2023, Dec 19)
• Clinical evaluation of a web-based personalized recommendation system with electronic health record interface to optimize healthcare resources during SARS-CoV-2 surges (Sci Rep., 2023, Dec 15)
• A SARS-CoV-2 Omicron outbreak among crew members on a cruise ship in Germany in early 2022 (International Maritime Health, 2023, Dec 15)
• tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2. (Biol Methods Protoc., 2023, Dec 12)
• Policy responses to the COVID-19 pandemic in West Africa: a scoping review protocol (BMJ Open., 2023, Dec 10)
• A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity. (Sci Rep., 2023, Dec 9)
• Berufsbedingte Unterschiede in COVID-19-Erkrankungen (ASU Arbeitsmed Sozialmed Umweltmed, 2023, Nov 29)
• Reconstructing relative transmission rates in Bayesian phylodynamics: Two-fold transmission advantage of Omicron in Berlin, Germany during December 2021 (Virus Evolution, 2023, Nov 29)
• Pandemic Preparedness im Rahmen der Internationalen Gesundheitsvorschriften (IGV): Die Rolle des ÖGD
• Why are different estimates of the effective reproductive number so different? A case study on COVID-19 in Germany. (PLOS Computational Biology, 2023, Nov 27)
• Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021. (Eurosurveillance, 2023, Nov 23)
• Day care study showed no differences in long-term symptoms in children who were and were not infected during COVID-19 outbreaks (Acta Paediatr., 2023, Oct 25)
• Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review (Lancet Glob Health., 2023, Oct 17)
• Managing and monitoring a pandemic: showcasing a practical approach for the genomic surveillance of SARS-CoV-2 (Database (Oxford), 2023, Oct 16)
• The Burden of Disease due to COVID-19 (BoCO-19): A study protocol for a secondary analysis of surveillance data in Southern and Eastern Europe, and Central Asia. (PLoS One, 2023, Oct 13)
• Scientific advisory councils in the COVID-19 response (The Lancet, 2023, Oct 12)
• Epidemiology of common infectious diseases before and during the COVID-19 pandemic in Bavaria, Germany, 2016 to 2021: an analysis of routine surveillance data (Euro Surveill., 2023, Oct 12)
• The Role of Vaccination Centers in a National Mass Immunization Campaign—Policymaker Insights from the German COVID-19 Pandemic Vaccine Roll-Out. (Vaccines, 2023, Sep 30)
• Reflections from the COVID-19 pandemic in Germany: lessons for global health (BMJ Global Health, 2023, Sep 25)
• Physical activity and physical fitness among children and adolescents after the onset of the COVID-19 pandemic in the WHO European Region: a systematic review protocol (BMJ Open, 2023, Sep 20)
• SARS-CoV-2 seroconversion in children attending daycare versus adults in Germany between October 2020 and June 2021 (Communications Medicine, 2023, Sep 15)
• Socioeconomic Differences in SARS-CoV-2 Infection and Vaccination in Germany: A Seroepidemiological Study After One Year of COVID-19 Vaccination Campaign (International Journal of Public Health, 2023, Sep 14)
• Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up (BMC Public Health, 2023, Aug 21)
• Results of German external quality assessment schemes for SARS-CoV-2 antigen detection (Sci Rep., 2023, Aug 14)
• Collaborative nowcasting of COVID-19 hospitalization incidences in Germany (PLoS Comput Biol., 2023, Aug 11)
• Neighbourhood watch: genomic epidemiology of SARS-CoV-2 variants circulating in a German federal state, Mecklenburg-Western Pomerania, in 2020-2022 (Emerg Microbes Infect., 2023, Aug 10)
• Impact of the COVID-19 pandemic on oncological care in Germany: rapid review. (J Cancer Res Clin Oncol, 2023, Jul 29)
• Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics. (PNAS Nexus, 2023, Jul 25)
• Providing strategic information during a public health emergency: lessons learned during the COVID-19 pandemic in Germany. (Evidence & Policy, 2023, Jul 21)
• The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant. (BMC Infectious Diseases, 2023, Jul 13)
• Essential public health functions: the key to resilient health systems. (BMJ Global Health, 2023, Jul 12)
• Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP) (Infection, 2023, July 11)
• COVID-19 cross-border case and contact tracing activities - experiences and lessons learnt, Germany, April-December 2020 (BMC Public Health, 2023, July 4)
• Seroepidemiological and Molecular Survey for the Detection of SARS-CoV-2 Infection among Children in Iran, September 2020 to June 2021: 1-Year Cross-Sectional Study. (Microorganisms., 2023, Jun 27)
• Strengthening COVID-19 pandemic response coordination through public health emergency operations centres (PHEOC) in Africa: Review of a multi-faceted knowledge management and sharing approach, 2020–2021 (PLOS Glob Public Health, 2023, Jun 22)
• Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study (Clinical Rheumatology, 2023, Jun 19)
• Three years into the pandemic: results of the longitudinal German COPSY study on youth mental health and health-related quality of life. (Frontiers in Public Health, 2023, Jun 15)
• Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021 (Eurosurveillance, 2023, Jun 15)
• Support- and meaning-focused coping as key factors for maintaining adult quality of life during the COVID-19 pandemic in Germany. (Front. Public Health, 2023, Jun 12)
• T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual (Microorganisms, 2023, June 12)
• Enhancing global preparedness during an ongoing pandemic from partial and noisy data (PNAS Nexus, 2023, Jun 7)
• A COVID-19 isolation facility for people experiencing homelessness in Berlin, Germany: a retrospective patient record study (Frontiers in Public Health, 2023, Jun 6)
• Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021 (Frontiers in Public Health, 2023, May 30)
• Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response. (Lancet, 2023, May 26)
• Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron (Journal of Clinical Virology, 2023, May 24)
• Direct and indirect vaccination effects on SARS-CoV-2 infection in day-care centres: Evaluating the policy for early vaccination of day-care staff in Germany, 2021 (Epidemiology and Infection, 2023, May 4)
• Lessons from COVID-19 for rescalable data collection (The Lancet Infectious Diseases, 2023, May 4)
• Changes in emergency department utilisation in Germany before and during different phases of the COVID-19 pandemic, using data from a national surveillance system up to June 2021 (BMC Public Health, 2023, May 2)
• An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective (Infection, 2023, May 2)
• SARS-CoV-2 infections in migrant populations in Germany: results from the COVID-19 snapshot monitoring survey (Public Health, 2023, Apr. 26)
• Social Media App Usage in Relation with PHQ-9 Depression Scores during the COVID-19 Pandemic (UbiComp/ISWC '22 Adjunct, 2023, Apr. 24)
• Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations. (Elife, 2023, Apr 21)
• Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany (Euro Surveill. 2023, Apr 20)
• Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis (The Lancet Child & Adolescent Health, 2023, Apr 18)
• Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations (The Lancet Infectious Diseases, 2023, Apr 14)
• Recovery and sequelae in 523 adults and children with tick-borne encephalitis in Germany (Infection, 2023, Apr.6)
• Effect of risk status for severe COVID-19 on individual contact behaviour during the SARS-CoV-2 pandemic in 2020/2021—an analysis based on the German COVIMOD study (BMC Infectious Diseases, 2023, Apr 6)
• New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic (European Respiratory Journal, 2023, Apr 3)
• Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 (Pathogens, 2023, Apr 2)
• Development of a risk score to identify patients at high risk for a severe course of COVID-19. (J Public Health, 2023, March 22)
• Modeling the impact of the Omicron infection wave in Germany (Biology Methods and Protocols, 2023, March 21)
• Subregional origins of emerging SARS-CoV-2 variants during the second pandemic wave in Côte d’Ivoire (Virus Genes, 2023, Mar 18)
• Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study (Infection, 2023, March 13)
• Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis. (European Journal of Medical Research volume, 2023, Feb 25)
• Time trends in mental health indicators in Germany's adult population before and during the COVID-19 pandemic (Frontiers Public Health, 2023, Feb 23)
• SARS-CoV-2 Prevalence on and Incidence after Arrival in Travelers on Direct Flights from Cape Town, South Africa to Munich, Germany Shortly after Occurrence of the Omicron Variant in November/December 2021: Results from the OMTRAIR Study (Pathogens, 2023, Feb 20)
• Telemedicine in emergency responses: reflections from a critical care telemedicine programme between Uzbekistani and German clinicians during COVID-19. (BMJ Health & Care Informatics, 2023, Feb 17)
• Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel. (Vaccine, 2023, Feb 16)
• Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review. (European Journal of Epidemiology, 2023, Feb 16)
• Estimating the share of SARS-CoV-2-immunologically naïve individuals in Germany up to June 2022 (Epidemiology & Infection, 2023, Feb 15)
• Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020 (Journal of Infection, 2023, Feb.14)
• Motivational readiness for physical activity and health literacy: results of a cross-sectional survey of the adult population in Germany. (BMC Public Health, 2023, Feb 14)
• Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19 (Nature Communications, 2023, Feb 11)
• Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany (BMC Infectious Diseases, 2023, Feb 10)
• Änderung des COVID-Symptom­profils während der Corona­pandemie - Analyse der deutschen Melde­daten (Deutsches Ärzteblatt, 10.2.2023)
• Situational pathogen avoidance mediates the impact of social connectedness on preventive measures during the COVID-19 pandemic (Scientific Reports, 2023, Feb 10)
• Visualization of SARS-CoV-2 particles in naso/oropharyngeal swabs by thin section electron microscopy (Virology Journal, 2023, Feb 6)
• Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022 (Journal of Hospital Infection, 2023, Feb 3)
• Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity (Sec. Viral Immunology, 2023, Jan 31)
• Prevalence of Positive COVID-19 Test Results Collected by Digital Self-report in the US and Germany (JAMA Network Open, 2023, Jan 31)
• Communicating risk during early phases of COVID-19: Comparing governing structures for emergency risk communication across four contexts (Front. Public Health, 2023, Jan 27)
• Remdesivir for the treatment of COVID‐19 (Cochranelibrary, 2023, Jan 25)
• COVID-19 isolation and quarantine orders in Berlin-Reinickendorf (Germany): How many, how long and to whom? (2023, Jan 24)
• From delta to omicron: The role of individual factors and social context in self-reported compliance with pandemic regulations and recommendations (Social Science & Medicine, 2023, Jan 23)
• Key lessons learnt from COVID-19 intra-action reviews in the Republic of Moldova, Montenegro, Kosovo and North Macedonia 2020–2021: a qualitative study (BMJ Open, 2023, Jan 23)
• Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. (Lancet Infect Dis., 2023, Jan 18)
• Understanding COVID-19 reporting behaviour to support political decision-making: a retrospective cross-sectional study of COVID-19 data reported to WHO (BMJ Open, 2023, Jan 5)
• Innovative Methods Used in Monitoring COVID-19 in Europe: A Multinational Study. (Int. J. Environ. Res. Public Health, 2022, Dec 29)
• Socioeconomic differences in the reduction of face-to-face contacts in the first wave of the COVID-19 pandemic in Germany (BMC Public Health, 2022, Dec 23)
• Inanspruchnahme des Rettungsdiensts bei Suizidversuchen im Verlauf der SARS-CoV-2-Pandemie. (Notfall Rettungsmed., 2022, Dec 20)
• Genomic Epidemiology of SARS-CoV-2 in Western Burkina Faso, West Africa. (Viruses, West Africa., 2022, Dec 14)
• Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic (2022, Dec 14)
• Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022 (Vaccine, 2022, Dec 2)
• What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector (Vaccine, 2022, Nov 25)
• Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories (Journal of Clinical Microbiology, 2022, Nov 29)
• Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier (Antiviral Research 2022, Nov 21)
• Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study (Influenza Other Respir Viruses, 2022, Nov 21)
• Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020 (PLoS ONE, 2022, Nov 17)
• The Burden of Disease in Germany at the National and Regional Level (Deutsches Ärzteblatt, 2022, Nov 18)
• Efficacy, Effectiveness and Safety of Vaccines Against COVID-19 for Children Aged 5-11 Years: A Living Systematic Review with Meta-Analysis (2022, Nov 18)
• Delta and Omicron: protective measures and SARS-CoV-2 infections in day care centres in Germany in the 4th and 5th wave of the pandemic 2021/2022 (BMC Public Health, 2022, Nov 17)
• SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression (PLOS Biology, 2022, Nov 16)
• SARS-CoV-2 viral clearance and viral load kinetics in young children (1–6 years) compared to adults: Results of a longitudinal study in Germany (Front. Pediatr., 2022, Nov 14)
• Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020 (Scientific Reports, 2022, Nov 14)
• Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event (BMJ Global Health, 2022, Nov 11)
• Participatory development and implementation of inclusive digital health communication on COVID-19 with homeless people (Frontiers in Public Health, 2022, Nov 10)
• Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany (PLOS Medicine, 2022, Nov 10)
• Symptomatik einer akuten SARS-CoV-2-Infektion bei Kindern im Kita-Alter (Monatsschrift Kinderheilkunde, 9.11.2022)
• Short and Long-Term Wellbeing of Children following SARS-CoV-2 Infection: A Systematic Review (International Journal of Environmental Research and Public Health, 2022, Nov 3)
• National and subnational short-term forecasting of COVID-19 in Germany and Poland during early 2021 (Communications Medicine, 2022, Oct 31)
• SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model (Communications Biology, 2022, Oct 27)
• Attack Rate for Wild-Type SARS-CoV-2 during Air Travel: Results from 46 Flights Traced by German Health Authorities, January-March and June-August 2020 (Canadian Journal of Infectious Diseases and Medical Microbiology, 2022, Oct 22)
• Time trends of mental health indicators in Germany's adult population before and during the COVID-19 pandemic (2022, Oct. 10)
• Adult quality of life patterns and trajectories during the COVID-19 pandemic in Germany (Current Psychology, 2022, Sep 30)
• Multicountry study of SARS-CoV-2 and associated risk factors among healthcare workers in Côte d'Ivoire, Burkina Faso and South Africa (Transactions of The Royal Society of Tropical Medicine and Hygiene, 2022, Sept 24)
• Impact of the COVID-19 pandemic on influenza and RSV antibody titres in the community – a prospective Cohort Study in Neustadt Thuringia/Germany (European Respiratory Journal, 2022, Sep 16)
• Germany’s fourth COVID-19 wave was mainly driven by the unvaccinated (Communications Medicine, 2022, Sep 16)
• The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance (Science, 2022, Sep 15)
• Fluvoxamine for the treatment of COVID‐19 (Cochrane Database of Systematic Reviews, 2022, Sep 14)
• Molecular characterization and evolution dynamics of influenza B viruses circulating in Germany from season 1996/1997 to 2019/2020 (Virus Research, 2022, Sep 10)
• BNT162b2 vaccination reduced infections and transmission in a COVID-19 outbreak in a nursing home in Germany, 2021. (Influenza Other Respi Viruses. 2022, Sep 9)
• Corona Monitoring Nationwide (RKI-SOEP-2): Seroepidemiological Study on the Spread of SARS-CoV-2 Across Germany (Jahrbücher für Nationalökonomie und Statistik, 2022, Sep. 7)
• Neue STIKO-Empfehlungen: Auffrischung der COVID-19-Impfung (Deutsches Ärzteblatt, 2022, Sep 5)
• SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany (Infection, 2022, Sep 1)
• Temporal Dynamics of Socioeconomic Inequalities in COVID-19 Outcomes Over the Course of the Pandemic - A Scoping Review (International Journal of Public Health, 2022, Aug 29)
• Facing the Omicron variant - how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review (Front. Immunol., 2022, Aug 24)
• 3D ex vivo tissue platforms to investigate the early phases of influenza A virus- and SARS-CoV-2-induced respiratory diseases (Emerging Microbes & Infections, 2022, Aug 24)
• Child and Adolescent Mental Health During the COVID-19 Pandemic: Results of the Three-Wave Longitudinal COPSY Study (Journal of Adolescent Health, 2022, Aug 18)
• Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map (International Journal of Environmental Research and Public Health, 2022, Aug 11)
• Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review (Cochrane Database of Systematic Reviews, 2022, Aug 9)
• Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) are even shorter compared to Delta (Epidemiology and Infection, 2022, Aug 5)
• Exploring pandemic-related health literacy among adolescents in Germany: a focus group study (Archives of Public Health, 2022, Aug 5)
• Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses (eBioMedicine, 2022, Aug 2)
• Regional disparities in SARS-CoV-2 infections by labour market indicators: a spatial panel analysis using nationwide German data on notified infections (BMC Infectious Diseases, 2022 Jul 30)
• Gendered impact of COVID-19 containment measures on unpaid care work and mental health in Europe: a scoping review protocol (BMJ open, 2022, Jul 27)
• Determinants of RSV epidemiology following suppression through pandemic contact restrictions (Epidemics, 2022, Jul 21)
• SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod (Journal of Neurology, Neurosurgery & Psychiatry, 2022, Jul 14)
• SARS-CoV-2-Ausbrüche in Alten- und Pflegeheimen in Deutschland. Eine epidemiologische Vergleichsanalyse zu den Zeiträumen vor und nach Beginn der Impfkampagne (Deustches Ärzteblatt, 2022, Jul 11)
• Transmission of SARS-CoV-2 among children and staff in German daycare centres (Epidemiology and Infection, 2022, Jul 8)
• Risks and Resources for Depressive Symptoms and Anxiety in Children and Adolescents During the COVID-19 Pandemic - Results of the Longitudinal COPSY Study (Frontiers in Psychiatry, 2022, Jul 7)
• CovRadar: Continuously tracking and filtering SARS-CoV-2 mutations for genomic surveillance. Bioinformatics (Bioinformatics, 2022, Jul 7)
• Using routine emergency department data for syndromic surveillance of acute respiratory illness, Germany, week 10 2017 until week 10 2021 (Eurosurveillance, 2022, Jul 7)
• COVID-19-Pandemie: Schlussfolgerungen aus krankenhaushygienischer Sicht (Deutsches Ärzteblatt, 2022, Jul 1)
• Continuous development of the semantic search engine preVIEW: from COVID-19 to long COVID (Database, 2022, Jul 1)
• A comparative analysis of experienced uncertainties in relation to risk communication during COVID19: a four-country study (Globalization and Health, 2022, Jun 27)
• Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021 (Clinical Infectious Disease, 2022, June 25)
• Burden of Disease of COVID-19: Strengthening the Collaboration for National Studies (Frontiers in Public Health, 2022, Jun 3)
• SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022 (Eurosurveillance, 2022, Jun 2)
• An early warning system for emerging SARS-CoV-2 variants (Nature Medicine, 2022, May 30)
• Continued false-positive detection of SARS-CoV-2 by electron microscopy (Annals of Neurology, 2022, May 14)
• A web-based app to provide personalized recommendations for COVID-19 (Nature Medicine, 2022, May 9)
• Coronapandemie: Die Rolle epidemiologischer Forschung in Gesundheitskrisen (Deutsches Ärzteblatt, 2022, April 29)
• Identification of coronavirus particles by electron microscopy requires demonstration of specific ultrastructural features (European Respiratory Journal, 2022, Apr 29)
• Estimating the distribution of COVID-19-susceptible, -recovered, and -vaccinated individuals in Germany up to April 2022 (2022, Apr 23)
• Data-driven prediction of COVID-19 cases in Germany for decision making (BMC Medical Research Methodology, 2022, Apr 20)
• MALDI-TOF-MS-Based Identification of Monoclonal Murine Anti-SARS-CoV-2 Antibodies within One Hour (Antibodies, 2022, Apr 14)
• N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro (Emerging Microbes & Infections, 2022, Apr 14)
• Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 (Vaccine, 2022, Apr 8)
• Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011–2021, Germany (Influenza and Other Respiratory Viruses, 2022, Apr 29)
• To disclose or not to disclose? Factors related to the willingness to disclose information to a COVID-19 tracing app (Information, Communication & Society, 2022, Mar 28)
• Health care workers’ experiences during the COVID-19 pandemic: a scoping review (Human Resources for Health, 2022, Mar 24)
• Timely Monitoring COVID-19 Vaccine Protection, Berlin, Germany, April 15th to December 15th, 2021 (International Journal of Public Health, 2022, Mar 21)
• Ultrastructural examination of lung “cryobiopsies” from a series of fatal COVID-19 cases hardly revealed infected cells (Virchows Archiv, 2022, Mar 16)
• Corrigendum: poreCov - An Easy to Use, Fast, and Robust Workflow for SARS CoV-2 Genome Reconstruction via Nanopore Sequencing (Frontiers in Genetics, 2022, Mar 14)
• Prognosemodelle zur Steuerung von intensivmedizinischen COVID-19-Kapazitäten in Deutschland (Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2022, Mar 10)
• RespiCoV: Simultaneous identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and 46 respiratory tract viruses and bacteria by amplicon-based Oxford-Nanopore MinION sequencing (PLOS ONE, 2022, Mar 9)
• Inhaled corticosteroids for the treatment of COVID‐19 (Cochrane Database of Systematic Reviews, 2022, Mar 9)
• Antibody escape and global spread of SARS-CoV-2 lineage A.27 (Nature Communications, 2022, Mar 3)
• Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2 (Scientific Reports, 2022, Mar 3)
• Preparing for patients with high-consequence infectious diseases: Example of a high-level isolation unit (PLOS ONE, 2022, Mar 3)
• Results of the enhanced COVID-19 surveillance during UEFA EURO 2020 in Germany (Epidemiology and Infection, 2022, Mar 3)
• High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey (Clinical Infectious Disease, 2022, Mar 1)
• Classification Schemes of COVID-19 High Risk Areas and Resulting Policies: A Rapid Review (Frontiers in Public Health, 2022, Feb 25)
• Waning of COVID-19 vaccine effectiveness: individual and public health risk (The Lancet, 2022, Feb 23)
• Effectiveness and sustainability of the WHO multimodal hand hygiene improvement strategy in the University Hospital Bouaké, Republic of Côte d'Ivoire in the context of the COVID-19 pandemic (Antimicrobial Resistance & Infection Control, 2022, Feb 17)
• Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany (BMC Infectious Diseases, 2022, Jan 24)
• RNA reference materials with defined viral RNA loads of SARS-CoV-2—A useful tool towards a better PCR assay harmonization (PLoS ONE, 2022, Jan 20)
• Lateral flow–based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use (Analytical and Bioanalytical Chemistry, 2022, Jan 19)
• COVID-19 infections in day care centres in Germany: social and organisational determinants of infections in children and staff in the second and third wave of the pandemic (BMC Public Health, 2022, Jan 14)
• SARS-CoV-2 outbreaks in hospitals and long-term care facilities in Germany: a national observational study (The Lancet Regional Health Europe, 2022, Jan 13)
• Changes in healthcare seeking and lifestyle in old aged individuals during COVID-19 lockdown in Germany: the population-based AugUR study (BioMed Central, BMC Geriatrics, 2022, Jan 8)
• Household clusters reveal household- and variant-specific properties of SARS-CoV-2 (Epidemiology and Infection, 2022, Jan 7)
• Contact Tracing with the Exposure Notification Framework in the German Corona-Warn-App (IEEE Explore, 2022, Jan 4)
• Deep time course proteomics of SARS-CoV- and SARS-CoV-2-infected human lung epithelial cells (Calu-3) reveals strong induction of interferon-stimulated gene expression by SARS-CoV-2 in contrast to SARS-CoV (Journal of Proteome Research, 2022, Jan 4)
• Investigation of a Limited but Explosive COVID-19 Outbreak in a German Secondary School (Viruses, 2022, Jan 4)
• Digital visual communication for public health: a design proposal for a vaccinated emoji (2021, Dec 29)
• SARS-CoV-2 aerosol transmission indoors: a closer look at viral load, infectivity, the effectiveness of preventive measures and a simple approach for practical recommendations (International Journal of Environmental Research and Public Health, 2021, Dec 25)
• SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis (Cell, 2021, Dec 22)
• Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2 (NPJ Vaccines, 2021, Dec 20)
• SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi (International Journal of Infectious Diseases, 2021, Dec 17)
• SARS-CoV-2 transmissibility within day care centers – study protocol of a prospective analysis of outbreaks in Germany (Frontiers in Public Health, 2021, Dec 13)
• Monitoring for COVID-19 by universal testing in a homeless shelter in Germany: a prospective feasibility cohort study (BMC Infectious Diseases, 2021, Dec 11)
• Recurrent SARS-CoV-2 infections and their potential risk to public health – a systematic review (PLoS One, 2021, Dec 9)
• Impact of the COVID-19 pandemic on ongoing health research: an ad hoc survey among investigators in Germany (BMJ Open, 2021, Dec 6)
• SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis (Cell, 2021, Nov 27)
• Therapie und Prophylaxe: Antikörper gegen COVID-19 (Deutsches Ärzteblatt, 2021, Nov 27)
• Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses (Allergy, 2021, Nov 25)
• Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study (2021, Nov 24)
• Discrimination of SARS-CoV-2 infections from other viral respiratory infections by scent detection dogs (Frontiers in Medicine, 2021, Nov 18)
• Infektionsrisiko mit SARS-CoV-2 von Beschäftigten in Gesundheitsberufen während der Pandemie (Deutsches Ärzteblatt, 2021, Nov 16)
• Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021 (Eurosurveillance, 2021, Nov 11)
• Neue Therapiealgorithmen: COVID-19 von leicht bis schwer richtig behandeln (Deutsches Ärzteblatt, 2021, Nov 5)
• Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 (Eurosurveillance, 2021, Nov 4)
• Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 (Eurosurveillance, 2021, Nov 4)
• Estimate of exposure to SARS-CoV-2 and performance of high-risk interventions by European anaesthesiologists: a Pan-European cross-sectional survey (European Journal of Anaesthesiology, 2021, Nov 4)
• Seroprevalence and risk factors of COVID-19 in healthcare workers from eleven African countries: a scoping review and appraisal of existing evidence (Health Policy and Planning, 2021, Nov 2)
• Emerging socioeconomic disparities in COVID-19-related deaths during the second pandemic wave in Germany (International Journal of Infectious Diseases, 2021, Oct 29)
• A longitudinal study on symptom duration and 60-day clinical course in non-hospitalised COVID-19 cases in Berlin, Germany, March to May, 2020 (Eurosurveillance, 2021, Oct 28)
• Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany) (Epidemiology and Infection, 2021, Oct 26)
• Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19 (2021, Oct 22)
• Finding disease outbreak locations from human mobility data (EPJ Data Science, 2021, Oct 19)
• Surveillance of endemic human Coronaviruses in Germany, 2019/2020 (Lancet Regional Health - Europe, 2021, Oct 18)
• Analysis of SARS-CoV-2 replication in explant cultures of the human upper respiratory tract reveals broad tissue tropism of wild-type and B.1.1.7 variant viruses (Journal of Infectious Diseases, 2021, Oct 15)
• Individual social contact data and population mobility data as early markers of SARS-CoV-2 transmission dynamics during the first wave in Germany—an analysis based on the COVIMOD study (BMC Medicine, 2021, Oct 14)
• Low sensitivity of rapid antigen tests to detect SARS-CoV-2 infections prior to and on the day of symptom onset in staff and residents of a nursing home, Germany, January–March 2021 (Journal of Infectious Diseases, 2021, Oct 14)
• Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021 (Eurosurveillance, 2021, Oct 14)
• Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020 (Nature Communications, 2021, Oct 14)
• Detection of neutralizing antibodies against SARS-CoV-2 by using a commercial surrogate virus neutralization ELISA: can it substitute the classical neutralization test? (2021, Oct 14)
• Seroprävalenz von COVID-19 und psychosoziale Auswirkungen in der Allgemeinbevölkerung: Ergebnisse des STAAB-COVID-One Programms (Gesundheitswesen, 2021, Oct 12)
• Quality of life and mental health in children and adolescents during the first year of the COVID-19 pandemic: results of a two-wave nationwide population-based study (European Child and Adolescent Psychiatry, 2021, Oct 12)
• COVID-19 pandemic & bureaucracy: the crisis inside the crisis (Frontiers in Public Health, 2021, Oct 7)
• Cardiovascular consequences of viral infections: from COVID to other viral diseases (Cardiovascular Research, 2021, Oct 5)
• Analysis of SARS-CoV-2 RNA stability and infectivity in oropharyngeal swab samples (2021, Oct 5)
• Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions (Nature Communications, 2021, Oct 1)
• Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort (Journal of Epidemiology and Community Health, 2021, Sep 28)
• Socioeconomic inequalities in the prevalence and perceived dangerousness of SARS-CoV-2 infections in two early German hotspots: findings from a seroepidemiological study (BMC Research Notes, 2021, Sept 26)
• Functioning of the International Health Regulations during the COVID-19 pandemic (The Lancet, 2021, Sept 24)
• COVID-19 outbreaks in settings with precarious housing conditions in Germany: challenges and lessons learned (Frontiers in Public Health, 2021, Sep 21)
• Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform (Vaccine, 2021, Sept 16)
• De-escalation strategies for non-pharmaceutical interventions following infectious disease outbreaks: a rapid review and a proposed dynamic de-escalation framework (Globalization and Health, 2021, Sep 16)
• A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa (Science, 2021, Sep 9)
• The containment scouts: first insights into an initiative to increase the public health workforce for contact tracing during the COVID-19 pandemic in Germany (International Journal of Environmental Research and Public Health, 2021, Sep 3)
• Sociodemographic characteristics determine download and use of a Corona contact tracing app in Germany-Results of the COSMO surveys (PLOS ONE, 2021, Sep 2)
• Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey (Journal of Antimicrobial Chemotherapy, 2021, Sep 2)
• Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection (Eurosurveillance, 2021, Sep 1)
• Cross-reactive CD4⁺ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination (Science, 2021, Aug 31)
• A pre-registered short-term forecasting study of COVID-19 in Germany and Poland during the second wave (Nature Communications, 2021, Aug 27)
• Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence (BMC Medicine, 2021, Aug 27)
• Inactivation of coronaviruses during sample peparation for proteomics experiments (Journal of Proteome Research, 2021, Aug 25)
• COVID-19: an opportunity to re-evaluate the implementation of a One Health approach to tackling emerging infections in Nigeria and other sub-Saharan African countries (Journal of the Egyptian Public Health Association, 2021, Aug 20)
• Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2 (PNAS, 2021, Aug 10)
• Verhaltensänderungen beim Tabak- und Alkoholkonsum in Kupferzell (Baden-Württemberg) während der Maßnahmen zur Eindämmung der COVID-19-Pandemie (Deutsches Ärzteblatt, 2021, Aug 8)
• Quantifying Covid19-vaccine location strategies for Germany (BMC Health Services Research, 2021, Aug 7)
• Toward a common performance and effectiveness terminology for digital proximity tracing applications (Frontiers in Digital Health, 2021, Aug 5)
• Hot days and Covid-19: Online survey of nurses and nursing assistants to assess occupational heat stress in Germany during summer 2020 (The Journal of Climate Change and Health, 2021, Aug 1)
• Rise and fall of SARS-CoV-2 lineage A.27 in Germany (Viruses, 2021, Jul 29)
• poreCov – an easy to use, fast, and robust workflow for SARS-CoV-2 genome reconstruction via nanopore sequencing (Frontiers in Genetics, 2021, Jul 28)
• Public Health Effects of Travel-Related Policies on the COVID-19 Pandemic: A Mixed-Methods Systematic Review (Journal of Infection, 2021, Jul 24)
• Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients (International Journal of Infectious Diseases, 2021, Jul 22)
• Perceived Access to Health Care Services and Relevance of Telemedicine during the COVID-19 Pandemic in Germany (International Journal of Environmental Research and Public Health, 2021, Jul 19)
• Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 (Euro Surveill., 2021, Jul 15)
• Public perception of the German COVID-19 contact-tracing app Corona-Warn-App (2021 IEEE 34th International Symposium on CBMS, 2021, Jul 12)
• Corona Health—A Study- and Sensor-Based Mobile App Platform Exploring Aspects of the COVID-19 Pandemic (International Journal of Environmental Research and Public Health, 2021, Jul 10)
• Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020 (Cambridge University Press, Epidemiology and Infection, 2021, Jul 02)
• Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2 (BMC Public Health, 2021, Jun 21)
• Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19 (Journal of Infection, 2021, Jun 20)
• Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020 (The Lancet Regional Health - Europe, 2021, Jun 19)
• Indications of depressive symptoms during the COVID-19 pandemic in Germany: comparison of national survey and Twitter data (JMIR Mental Health, 2021, Jun 18)
• SARS-CoV-2 among migrants and forcibly displaced populations: a rapid systematic review (Journal of Migration and Health, 2021, Jun 16)
• The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states (European Journal of Epidemiology, 2021, Jun 10)
• “How Come You Don’t Call Me?” Smartphone communication app usage as an indicator of loneliness and social well-being across the adult lifespan during the COVID-19 pandemic (International Journal of Environmental Research and Public Health, 2021, Jun 8)
• Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany (Emerging Infectious Diseases, 2021, Jun 8)
• Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January – September 2020: Analysis of national surveillance data (The Lancet Regional Health - Europe, 2021, Jun 7)
• High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey (Clinical Infectious Diseases, 2021, Jun 5)
• Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2 (Virology Journal, 2021, Jun 2)
• AmpliCoV: Rapid whole-genome sequencing using multiplex PCR amplification and real-time Oxford Nanopore MinION sequencing enables rapid variant identification of SARS-CoV-2 (Frontiers in Microbiology, 2021, Jul 1)
• Real-time monitoring of COVID-19 dynamics using automated trend fitting and anomaly detection (Phil. Trans. R. Soc. B, 2021, May 31)
• SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021 (Eurosurveillance, 2021, May 27)
• Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 (Wellcome Open Reserach, 2021, May 19)
• Social media for field epidemiologists (#SoMe4epis): How to use Twitter during the #COVID19 pandemic (International Journal of Infectious Diseases, 2021, May 19)
• The four weeks before lockdown during the COVID-19 pandemic in Germany: a weekly serial cross-sectional survey on risk perceptions, knowledge, public trust and behaviour, 3 to 25 March 2020 (Eurosurveillance, 2021, May 17)
• "Disease surveillance for the COVID-19 era": time for bold changes The Lancet, Volume 397, Issue 10292, 19–25 June 2021
• Differences in risk perception, knowledge and protective behaviour regarding COVID-19 by education level among women and men in Germany. Results from the COVID-19 Snapshot Monitoring (COSMO) study (PLOS ONE, 2021, May 12)
• Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19 (Molecular and Cellular Probes, 2021, May 08)
• COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation (Patterns, 2021, Apr 20)
• An intra-host SARS-CoV-2 dynamics model to assess testing and quarantine strategies for incoming travelers, contact person management and de-isolation (Patterns, 2021, Apr 20)
• Sozioökonomische Unterschiede im Infektionsrisiko während der zweiten SARS-CoV-2-Welle in Deutschland (Deutsches Ärzteblatt, 2021, Apr 16)
• Cancelled routine vaccination appointments due to COVID-19 pandemic in Germany (Vaccine: X, 2021, Apr 1)
• Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020 (Emerg Infect Dis., 2021, Apr)
• Amantadine inhibits SARS-CoV-2 in vitro (Viruses, 2021, Mar 24)
• How skeptics could be convinced (not persuaded) to get vaccinated against COVID-19 (2021, Mar 22)
• Emerging COVID-19 success story: Germany’s push to maintain progress (Exemplars in Global Health, 2021, March 20)
• Establishment of an evaluation panel for the decentralized technical evaluation of the sensitivity of 31 rapid detection tests for SARS-CoV-2 diagnostics (2021, May 13)
• COVID-19: cross-border contact tracing in Germany, February to April 2020 (Euro Surveill. 2021. Mar 11)
• Burden of Disease Methods: A Guide to Calculate COVID-19 Disability-Adjusted Life Years (International Journal of Public Health, 2021, Mar 05)
• SARS-CoV-2-Varianten: Evolution im Zeitraffer (Deutsches Ärzteblatt, 2021, Mar 03)
• Epidemiology and transmission characteristics of early COVID-19 cases, January 20 – March 19 2020, in Bavaria, Germany (Cambridge University Press, Epidemiology and Infection, 2021, Mar 02)
• Application of spectral library prediction for parallel reaction monitoring of viral peptides. (Wiley, Proteomics, 2021, Feb 22)
• Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein. (Clinical Translational Medicine, 2021, Jan 17)
• Challenges in interpreting SARS-CoV-2 serological results in African countries. (The Lancet Global Health, 2021, Feb 17)
• Co-producing the Covid-19 response in Germany, Hong Kong, Lebanon, and Pakistan (BMJ, 2021, Feb 16)
• COVID-19-Krankheitslast in Deutschland im Jahr 2020 - Durch Tod und Krankheit verlorene Lebensjahre im Verlauf der Pandemie (Dtsch Arztebl, 2021, Feb 12)
• Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin sections of infected Vero cell cultures (Scientific Report, 2020, Feb 10)
• „Der Mensch, der Handball spielt, braucht den Ball, den Kontakt und die Gemeinschaft“ – Veränderungen im Sportangebot durch die COVID-19 Pandemie und deren Bedeutung für Sportvereine. (Das Gesundheitswesen, 2020, Jan 28)
• Improving National Intelligence for Public Health Preparedness: a methodological approach to finding local multi-sector indicators for health security. (BMJ Global Health, 2021, Jan 25)
• Impact of the COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany. (Eur Child Adolesc Psychiatry, 2021, Jan 25)
• The European tiered approach for virucidal efficacy testing – rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseases. (Euro Surveill., 2021, Jan 21)
• Using EM data to understand COVID-19 pathophysiology - Authors' reply (The Lancet, 2021, Jan 16)
• Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020. (Euro Surveill., 2021, Jan 14)
• Does the COVID-19 pandemic threaten global solidarity? Evidence from Germany (World Development, 2021)
• Development of vaccines at the time of COVID-19 (microLife, 2020, 17 Dec)
• COVID-19 in Central Asia: Uzbekistan's new approach to international cooperation (The Lancet Regional Health - Europe, 2020, Dec 15)
• Perceptions of health care use in Germany during the COVID-19 pandemic (Int J Environ Res Public Health, 2020 Dec 14)
• The Impact of the COVID-19 Pandemic and Associated Public Health Measures on Other Notifiable Infectious Diseases Under National Surveillance in Germany, Week 1-2016 – Week 32-2020 (2020, Dec 14)
• Variable sensitivity in molecular detection of SARS-CoV-2 in European expert laboratories: external quality assessment, June - July 2020 ( J Clin Microbiol, 2020 Dec 9)
• COVID-19 lockdown induces disease-mitigating structural changes in mobility networks (PNAS, 2020 Dec 3)
• Severe acute respiratory syndrome coronavirus 2 outbreak related to a nightclub, Germany (CDC, Emerg Infect Dis., 2020 Dec 2)
• Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 (Nature Neuroscience, 30.11.2020)
• Psychische Gesundheit und Lebensqualität von Kindern und Jugendlichen während der COVID-19-Pandemie – Ergebnisse der COPSY-Studie (Deutsches Ärzteblatt, 2020, Nov. 27)
• Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020 (Euro Surveill., 26.11.2020)
• SARS-CoV-2: Testergebnisse richtig einordnen (Dtsch Ärztebl, 20.11.2020)
• Assessing COVID-19 through the lens of health systems’ preparedness: time for a change. (Globalization and Health, 2020, Nov 19)
• Corona-Schnelltests – die Prävalenz macht’s! (ÄrzteZeitung, 17.11.2020)
• How to determine when SARS-CoV-2 antibody testing is or is not useful for population screening: a tutorial. (MDM Policy & Practice, 2020 Nov 5)
• COVID-19 – Meldedatenanalyse zu Infektionen im Gesundheitswesen (Dtsch Ärztebl Int, 2020)
• Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research (Briefings in Bioinformatics, 2020 Nov 4)
• Perspective on proteomics for virus detection in clinical samples (Journal of Proteome Research, 2020 Oct 22)
• Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany (Epidemiology & Infection, 2020 Oct 13)
• "Living with the COVID-19 pandemic: act now with the tools we have", The Lancet, Volume 396, Issue 10259, 24–30 October 2020
• Risk of human‐to‐wildlife transmission of SARS-CoV-2 (Mammal Review, 2020 Oct 6)
• Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral (The Lancet, 2020 Oct 5)
• Wirksam­keit nicht-pharma­zeu­tischer Inter­ven­tionen bei der Kontrolle der COVID-19-Pandemie (28.9.2020)
• Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe (The Lancet, 2020 Sept 24)
• Surveillance of COVID-19 school outbreaks, Germany, March to August 2020 (Euro Surveill. 2020 Sep 23)
• Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany (Eurosurveill, 2020 Sept 10)
• Soziale Ungleichheit und COVID-19: Sozialepidemiologische Perspektiven auf die Pandemie (Gesundheitswesen, 28.8.2020)
• The COVID-19 pandemic: diverse contexts; different epidemics - how and why? (BMJ Global Health, 2020, July)
• SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 (Nature, 2020 July 29)
• Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study (Lancet Respir Med 2020 July 28)
• Lessons From History: What Can We Learn From 300 Years of Pandemic Flu That Could Inform the Response to COVID-19? (Editorial, Am J Public Health 2020 Aug.)
• Excess All-Cause Mortality During the COVID-19 Pandemic in Europe - Preliminary Pooled Estimates From the EuroMOMO Network, March to April 2020 (Euro Surveill. 2020 Jul 25)
• Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany (Euro Surveill., 2020 Jun 11)
• COVID-19 and public support for development assistance. (2020, Jun 9)
• High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020 (Euro Surveill., 2020 Jun 4)
• Population vulnerability to COVID-19 in Europe: a burden of disease analysis (Archives of Public Health, 2020 May 29)
• Impact of sex and gender on COVID-19 outcomes in Europe (Biology of Sex Differences, 2020 May 25)
• Investigation of a COVID-19 Outbreak in Germany Resulting From a Single Travel-Associated Primary Case: A Case Series (Lancet Infect Dis, 2020 May 15)
• Letter to the editor: SARS-CoV-2 and enhancing antibodies (J. Clin. Virol., 2020 May 7)
• COVID-19: Travel health and the implications for sub-Saharan Africa (Travel Medicine and Infectious Diseases, 2020 Apr 9)
• Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China (Science, 2020 Apr 8)
• Monitoring behavioural insights related to COVID-19 (Lancet, 2020 Apr 2)
• COVID-19: towards controlling of a pandemic (Lancet, 2020 Mar 28)
• Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19) (Euro Surveill. 2020 Mar)
• First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 (Euro Surveill. 2020 Mar)
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (Cell. 2020 Mar 4) 
• Germany COVID-19 Snapshot MOnitoring (COSMO Germany): Monitoring knowledge, risk perceptions, preventive behaviours, and public trust in the current coronavirus outbreak in Germany. (2020, Mar 3)
• COVID-19: what is next for public health? (The Lancet, 2020 Feb 22)
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 1 (03.03.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 2 (10.03.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 3 (17.03.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 4 (24.03.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 5 (31.03.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 6 (07.04.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 7 (14.04.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 8 (21.04.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 9 (28.04.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 10 (05.05.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 11 (12.05.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 12 (19.05.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 13 (26.05.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 14 (09.06.2020).
• German COVID-19 Snapshot Monitoring (COSMO) – Welle 15 (23.06.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 16 (07.07.2020).
• German COVID-19 Snapshot Monitoring (COSMO) - Welle 17 (21.07.2020).

to the top